Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data

Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data

Abstract Purpose Despite the poor prognosis of triple-negative breast cancer (TNBC), it has been demonstrated that neoadjuvant immunotherapy in combination with chemotherapy can improve the pathologic complete response (pCR) rate and/or long-term outcome of TNBC. However, there have been no real-wor...

Full description

Bibliographic Details
Main Authors: Heran Deng, Liying Wang, Na Wang, Kejin Zhang, Yanxia Zhao, Pengfei Qiu, Xiaowei Qi, Danhua Zhang, Fei Xu, Jieqiong Liu
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Cancer
Subjects:
Tripe-negative breast cancer
Neoadjuvant immunotherapy
Anti-PD-1/L1 antibody
Real-world study
Online Access:https://doi.org/10.1186/s12885-023-10515-z

Internet

https://doi.org/10.1186/s12885-023-10515-z

Similar Items